Publications by authors named "Sam Acors"

Claim this Profile
A
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Nathan J Cheetham, Milla Kibble, Andrew Wong, Richard J Silverwood, Anika Knuppel, Sam Acors

Elife· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.
Julia S El-Sayed Moustafa, Anne U Jackson, Sarah M Brotman, Li Guan, Sergio Villicaña, Sam Acors

Int J Obes (Lond)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern.
Liane Dupont, Luke B Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Sam Acors

Nat Microbiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.
Carl Graham, Jeffrey Seow, Isabella Huettner, Hataf Khan, Neophytos Kouphou, Sam Acors

Immunity· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections.
Liane Dupont, Luke B Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Sam Acors

medRxiv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.
Nicola Sweeney, Blair Merrick, Rui Pedro Galão, Suzanne Pickering, Alina Botgros, Sam Acors

PLoS One· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike.
Carl Graham, Jeffrey Seow, Isabella Huettner, Hataf Khan, Neophytos Kouphou, Sam Acors

bioRxiv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
Philippa M Wells, Katie J Doores, Simon Couvreur, Rocio Martinez Nunez, Jeffrey Seow, Sam Acors

J Infect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
Jeffrey Seow, Carl Graham, Blair Merrick, Sam Acors, Suzanne Pickering

Nat Microbiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
Michael J Carter, Matthew Fish, Aislinn Jennings, Katie J Doores, Paul Wellman, Sam Acors

Nat Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings.
Suzanne Pickering, Gilberto Betancor, Rui Pedro Galão, Blair Merrick, Adrian W Signell, Sam Acors

PLoS Pathog· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis